GlassScriptPhysician profile
Brady P Nelson
NPI 1922103407
$10,834.20
in general payments reported to CMS, 2019-2025
34 companies · $3,228 in 2025
The $3,228 reported for 2025 was more than what 96% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,752 · 2023: $3,002 · 2024: $2,853 · 2025: $3,228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,936 · Education: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,935.81 |
| Education | $146.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,779.93 | 2022-2025 | Enbrel, Evenity, Otezla |
| Abbvie INC. | $2,134.55 | 2022-2025 | |
| Ucb, INC. | $1,469.29 | 2022-2025 | Cimzia, Bimzelx |
| Janssen Biotech, INC. | $983.20 | 2022-2025 | Tremfya |
| Pfizer INC. | $457.82 | 2022-2025 | |
| Glaxosmithkline, LLC. | $448.59 | 2022-2025 | Benlysta |
| Novartis Pharmaceuticals Corporation | $445.10 | 2022-2025 | |
| Radius Health, INC. | $305.28 | 2023-2025 | Tymlos |
| Lilly USA, LLC | $207.32 | 2022-2025 | Taltz, Zepbound |
| Horizon Therapeutics Plc | $187.04 | 2022-2023 | Krystexxa |
| Astrazeneca Pharmaceuticals LP | $183.52 | 2022-2025 | Saphnelo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.27 | 2023-2025 | Ofev, Cyltezo, Jascayd |
| Genentech USA, INC. | $143.35 | 2022-2025 | Actemra, Rituxan |
| E.R. Squibb & Sons, L.L.C. | $130.40 | 2024-2025 | Orencia |
| Aurinia Pharma U.S., INC. | $110.61 | 2023-2025 | Lupkynis |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $75.03 | 2023-2025 | Truxima |
| Bioventus LLC | $69.83 | 2022-2024 | Gelsyn-3 |
| Organon LLC | $63.02 | 2023-2024 | Hadlima |
| Sandoz INC. | $61.58 | 2024 | Hyrimoz |
| Celltrion USA INC. | $46.56 | 2023 | Yuflyma |
| Abbott Laboratories | $46.07 | 2023 | Proclaim |
| Fresenius Kabi USA, LLC | $42.11 | 2025 | |
| Almatica Pharma LLC | $40.01 | 2024-2025 | Teriparatide |
| Ani Pharmaceuticals, INC. | $38.34 | 2023-2024 | Purified Cortrophin Gel |
| Kiniksa Pharmaceuticals International, Plc | $34.41 | 2024 | Arcalyst |
| Genzyme Corporation | $24.95 | 2024 | |
| Tonix Medicines, INC. | $24.25 | 2025 | Tonmya |
| Sanofi-Aventis U.S. LLC | $19.57 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $19.32 | 2023 | Seglentis |
| Mallinckrodt Hospital Products INC. | $15.65 | 2024 | Acthar |
| Celgene Corporation | $14.89 | 2024 | Reblozyl |
| Depuy Synthes Sales INC. | $14.66 | 2024 | Orthovisc, Monovisc |
| Kiniksa Pharmaceuticals, LTD. | $13.94 | 2023 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $12.74 | 2025 | Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brady Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.